Categories Analysis, Consumer, LATEST

Key takeaways from Conagra’s (CAG) Q2 2024 earnings report

Adjusted EPS is now expected to range between $2.60-2.65 in FY2024

Shares of Conagra Brands, Inc. (NYSE: CAG) were down 2% on Thursday after the company reported mixed results for the second quarter of 2024. The branded foods seller also lowered its guidance for the full year on the basis of year-to-date results and slower volume recovery. Here are the key takeaways from the earnings report:

Sales miss, earnings beat

Conagra reported net sales of $3.21 billion for the second quarter of 2024, which was down 3.2% from the same period last year and below analysts’ projections of $3.24 billion. Organic sales were down 3.4%. GAAP net income decreased 25% year-over-year to $286 million, or $0.60 per share. Adjusted EPS fell 12% to $0.71 but surpassed estimates of $0.68.

Category performance

In Q2, Conagra’s organic sales decline was driven by a 2.9% drop in volume, mainly due to lower consumption trends. Volumes across the Grocery & Snacks and Refrigerated & Frozen segments were impacted by lower consumption trends leading to declines of 3.7% and 3.3%, respectively.

Sales decreased 4.1% in the Grocery & Snacks segment and 5.8% in the Refrigerated & Frozen segment in Q2. However, the company gained dollar share in snacking and staples categories such as microwave popcorn, chili, and hot cocoa as well as categories like frozen sides and frozen breakfast.

Sales in the International and Foodservice segments increased 8% and 4% respectively, with the International segment benefiting from volume growth of 3.3%, driven by strong performance in the Mexico business. The Foodservice segment saw price/mix increase by 6.8%, fueled by inflation-driven pricing actions, but volumes dropped 2.5%.

Lowered outlook

Conagra lowered its outlook for organic sales growth and adjusted EPS for the full year of 2024. The revised guidance reflects year-to-date performance, expectations for a slower volume recovery, and increased brand investments during the latter half of the year. The company now expects organic sales to decrease 1-2% compared to FY2023, versus its previous expectation for a growth of approx. 1%. Adjusted EPS is now expected to range between $2.60-2.65 versus the prior range of $2.70-2.75.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top